A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation.

Trial Profile

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Mar 2011

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension; Myocardial infarction; Stroke
  • Focus Therapeutic Use
  • Acronyms ACTIVE; ACTIVE-I
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Sep 2009 Results were presented during a Hot Line clinical trial session at the European Society of Cardiology (ESC) meeting.
    • 08 Oct 2008 Basic check conducted, added identifier and added to study centres spreadsheet; last updated 25 Sep 08.
    • 25 Sep 2008 Official title added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top